Reactive oxygen and nitrogen species: Implications for cardiovascular device engineering

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 83, Issue 1, 2007, Pages 138-144

  Kader, Khalid N ^a   Coyle, Christian H ^a  

^a IA United States   (United States)

Author keywords

Cardiovascular engineering; Reactive nitrogen species; Reactive oxygen species; Review; Shear

Indexed keywords

BIOMATERIALS; DISEASES; NITROGEN; OXYGEN;

CARDIOVASCULAR ENGINEERING; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

CARDIOVASCULAR SYSTEM;

BIOMATERIAL; OXIDIZING AGENT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

BIOMEDICAL ENGINEERING; BLOOD VESSEL WALL; CARDIOVASCULAR EQUIPMENT; CELL METABOLISM; CHEMICAL ENVIRONMENT; ENVIRONMENTAL FACTOR; ENZYME ASSAY; OXIDATIVE STRESS; PROSTHESIS FAILURE; REVIEW; SHEAR STRENGTH;

ANIMALS; CARDIOVASCULAR SYSTEM; HUMANS; OXIDANTS; OXIDATIVE STRESS; PROSTHESES AND IMPLANTS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 34648836536     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30777     Document Type: Review

References (75)

1. American Heart Association (AHA). Heart Disease and Stroke Statistics - 2005 Update. Dallas, Texas: American Heart Association; 2004.
2. Rhee SG. Redox signaling: Hydrogen peroxide as intracellular messenger. Exp Mol Med 1999;31:53-59.
3. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000;20: 2175-2183.
4. Brown MR, Miller FJ, Jr, Li WG, Ellingson AN, Mozena JD, Chatterjee P, Engelhardt JF, Zwacka RM, Oberley LW, Fang X, Spector AA, Weintraub NL. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells.[comment]. Circ Res 1999;85:524-533.
5. Patel RP, Moellering D, Murphy-Ullrich J, Jo H, Beckman JS, Darley-Usmar VM. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med 2000;28:1780-1794.
6. Stokes KY, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction: Role of nitric oxide and superoxide. Free Radic Biol Med 2002;33:1026-1036.
7. Anderson JM. Inflammatory response to implants. ASAIO Trans 1988;34:101-107.
8. Johnston RB, Jr, Lehmeyer JE, Guthrie LA. Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G. J Exp Med 1976;143:1551-1556.
9. Halliwell B. Production of superoxide, hydrogen peroxide and hydroxyl radicals by phagocytic cells: A cause of chronic inflammatory disease? Cell Biol Int Rep 1982;6:529-542.
10. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046-2050.
11. Granger DN, Vowinkel T, Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension 2004;43:924-931.
12. Kawamoto R, Yamashita A, Nishihira K, Furukoji E, Hatakeyama K, Ishikawa T, Imamura T, Itabe H, Eto T, Asada Y. Different inflammatory response and oxidative stress in neointimal hyperplasia after balloon angioplasty and stent implantation in cholesterol-fed rabbits. Pathol Res Pract 2006; 202:447-456.
13. Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Witztum JL, Strauss BH. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein (a): Short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 2004;109:3164-3170.
14. Coyle CH, Mendralla S, LaNasa S, Kader KN. Endothelial cell seeding onto various biomaterials causes superoxide-induced cell death. J Biomater Appl, in press.
15. Ushio-Fukai M. Redox signaling in angiogenesis: Role of NADPH oxidase. Cardiovasc Res 2006;71:226-235.
16. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PI, Johnson C, Alexander RW. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002;91:1160-1167.
17. Li WG, Miller FJ, Jr, Zhang HJ, Spitz DR, Oberley LW, Weintraub NL. H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 2001;276:29251-29256.
18. 2-induced oxidative stress in endothelial cells. Free Radic Biol Med 2006;40:2206-2213.
19. Hamilton CA, Miller WH, Al-Benna S, Brosnan MJ, Drummond RD, McBride MW, Dominiczak AF. Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci (Lond) 2004;106:219-234.
20. Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998;14:241-249.
21. Muller S, Konig I, Meyer W, Kojda G. Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate. J Am Coll Cardiol 2004;44:624-631.
22. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003;92:81-87.
23. Zhang DX, Zou AP, Li PL. Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries. Am J Physiol Heart Circ Physiol 2003;284: H605-H612.
24. Fridovich I. Superoxide dismutases: Regularities and irregularities. Harvey Lect 1983;79:51-75.
25. Hassan HM, Fridovich I. Chemistry and biochemistry of superoxide dismutases. Eur J Rheumatol Inflamm 1981;4: 160-172.
26. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 2000;20:1430-1442.
27. Yang MX, Cederbaum AI. Role of cytochrome b5 in NADH-dependent microsomal reduction of ferric complexes, lipid peroxidation, and hydrogen peroxide generation. Arch Biochem Biophys 1995;324:282-292.
28. Wolin MS, Davidson CA, Kaminski PM, Fayngersh RP, Mohazzab HK. Oxidant-nitric oxide signalling mechanisms in vascular tissue. Biochemistry (Mosc) 1998;63:810-816.
29. Davidson CA, Kaminski PM, Wolin MS. NO elicits prolonged relaxation of bovine pulmonary arteries via endogenous peroxynitrite generation. Am J Physiol 1997;273(2, Part 1): L437-L444.
30. Wink DA, Mitchell JB. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998;25:434-456.
31. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: Molecular and cellular mechanisms. Hypertension 2003;42:1075-1081.
32. Wassmann S, Wassmann K, Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 2004;44:381-386.
33. Wolin MS, Gupte SA, Oeckler RA. Superoxide in the vascular system. J Vasc Res 2002;39:191-207.
34. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003;285:R277-R297.
35. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 2001;88:44-51.
36. Beretta S, Sala G, Mattavelli L, Ceresa C, Casciati A, Ferri A, Carri MT, Ferrarese C. Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine. Neurobiol Dis 2003;13:213-221.
37. Harrison DG, Cai H, Landmesser U, Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2003;4:51-61.
38. Miyachi Y, Yoshioka A, Imamura S, Niwa Y. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 1986;86:449-453.
39. Parthasarathy S, Wieland E, Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci USA 1989;86:1046-1050.
40. Mertens A, Holvoet P. Oxidized LDL and HDL: Antagonists in atherothrombosis. Faseb J 2001;15:2073-2084.
41. Luchtefeld M, Drexler H, Schieffer B. 5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activation. Biochem Biophys Res Commun 2003;308:668-672.
42. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;266:4244-4250.
43. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: Implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 2003;278:22546-22554.
44. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Elbim C. Phagocyte NADPH oxidase: A multicomponent enzyme essential for host defenses. Arch Immunol Ther Exp (Warsz) 2005;53:199-206.
45. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood 1998;92:3007-3017.
46. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003;24:471-478.
47. Brandes RP. Role of NADPH oxidases in the control of vascular gene expression. Antioxid Redox Signal 2003;5:803-811.
48. Ohno Y, Gallin JI. Diffusion of extracellular hydrogen peroxide into intracellular compartments of human neutrophils. Studies utilizing the inactivation of myeloperoxidase by hydrogen peroxide and azide. J Biol Chem 1985;260:8438-8446.
49. Rhee SG, Bae YS, Lee SR, Kwon J. Hydrogen peroxide: A key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000;2000:PE1.
50. Dreher D, Junod AF. Differential effects of superoxide, hydrogen peroxide, and hydroxyl radical on intracellular calcium in human endothelial cells. J Cell Physiol 1995;162: 147-153.
51. Chen XL, Zhang Q, Zhao R, Medford RM. Superoxide, H2O2, and iron are required for TNF-α-induced MCP-1 gene expression in endothelial cells: Role of Rac1 and NADPH oxidase. Am J Physiol Heart Circ Physiol 2004;286:H1001-H1007.
52. Cai H. Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences. Cardiovasc Res 2005;68:26-36.
53. Channon KM, Guzik TJ. Mechanisms of superoxide production in human blood vessels: Relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 2002;53(4, Part 1):515-524.
54. Wattanapitayakul SK, Weinstein DM, Holycross BJ, Bauer JA. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. Faseb J 2000;14:271-278.
55. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: A question of balance. FEBS Lett 1995;369: 131-135.
56. Faraci FM, Didion SP. Vascular protection: Superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 2004;24:1367-1373.
57. Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 2000;28:1717-1725.
58. Visseren FL, Verkerk MS, van der Bruggen T, Marx JJ, van Asbeck BS, Diepersloot RJ. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest 2002;32(Suppl 1):84-90.
59. Kvietys PR, Inauen W, Bacon BR, Grisham MB. Xanthine oxidase-induced injury to endothelium: Role of intracellular iron and hydroxyl radical. Am J Physiol 1989;257(5, Part 2): H1640-H1646.
60. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
61. von Harsdorf R, Li PF, Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999;99:2934-2941.
62. Brunori M, Giuffre A, Sarti P, Stubauer G, Wilson MT. Nitric oxide and cellular respiration. Cell Mol Life Sci 1999;56: 549-557.
63. MacMillan-Crow LA, Thompson JA. Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys 1999;366:82-88.
64. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: Structure, function and inhibition. Biochem J 2001; 357(Part 3):593-615.
65. Kaysen GA, Eiserich JP. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol 2004;15:538-548.
66. Gotoh N, Niki E. Rates of interactions of superoxide with vitamin E, vitamin C and related compounds as measured by chemiluminescence. Biochim Biophys Acta 1992;1115:201-207.
67. Fontana L, McNeill KL, Ritter JM, Chowienczyk PJ. Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings. Br J Pharmacol 1999;126: 730-734.
68. d'Uscio LV, Milstien S, Richardson D, Smith L, Katusic ZS. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 2003;92:88-95.
69. Toth M, Kukor Z, Valent S. Chemical stabilization of tetrahydrobiopterin by L-ascorbic acid: Contribution to placental endothelial nitric oxide synthase activity. Mol Hum Reprod 2002;8:271-280.
70. Baker TA, Milstien S, Katusic ZS. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 2001;37:333-338.
71. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean. Br J Pharmacol 2004;142:231-255.
72. Lee MC, Yoshino F, Shoji H, Takahashi S, Todoki K, Shimada S, Kuse-Barouch K. Characterization by electron spin resonance spectroscopy of reactive oxygen species generated by titanium dioxide and hydrogen peroxide. J Dent Res 2005;84:178-182.
73. Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen and nitrogen: In vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 2004;286:R431-R444.
74. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: Nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 2001;89:224-236.
75. Munzel T, Afanas'ev IB, Kleschyov AL, Harrison DG. Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol 2002;22:1761-1768.